Seasoned growth- and operations-focused investor with a background in scaling technology and services businesses across North America and Europe, often leading board-level strategy, M&A and capital formation. CLINE REASOR combines operating leadership with private equity and venture capital experience, advising portfolio companies on go-to-market, cost structure and governance. Relevant expertise includes commercial transformation, cross-border expansion and capital markets readiness; typically targets Series B–growth buyouts in SaaS, fintech and industrial services.
Seasoned growth- and operations-focused investor with a background in scaling technology and services businesses across North America and Europe, often leading board-level strategy, M&A and capital formation. CLINE REASOR combines operating leadership with private equity and venture capital experience, advising portfolio companies on go-to-market, cost structure and governance. Relevant expertise includes commercial transformation, cross-border expansion and capital markets readiness; typically targets Series B–growth buyouts in SaaS, fintech and industrial services.
Operator-led growth investor focused on scaling SaaS, fintech and industrial services businesses at Series B through growth buyout stages. Prefers lead or control positions that enable board-level influence and hands-on commercial transformation, cost-profile optimization and capital markets preparation. Investment decisions prioritize durable unit economics, repeatable go-to-market models and cross-border expansion capability. Typical horizon targets value-accretive exits via M&A or IPO within a multi-year growth cycle, deploying staged capital with disciplined performance milestones.
Operator-led growth investor focused on scaling SaaS, fintech and industrial services businesses at Series B through growth buyout stages. Prefers lead or control positions that enable board-level influence and hands-on commercial transformation, cost-profile optimization and capital markets preparation. Investment decisions prioritize durable unit economics, repeatable go-to-market models and cross-border expansion capability. Typical horizon targets value-accretive exits via M&A or IPO within a multi-year growth cycle, deploying staged capital with disciplined performance milestones.
| Trades 1202 | Longs Won 879/1202 73% | Profit Factor 28.69 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.29M |
| Average Win $251,549.24 | Best Trade (Aug 14) $24.91M | Sharpe Ratio -9.88 |
| Average Loss -$23,859.23 | Worst Trade (Sep 01) -$874,962.18 | Z-Score 11.32 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3m 2w 1d | Expectancy $177,541.81 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 33,333 | 30,000 | 26,667 | 23,333 | 20,000 | 16,667 | 13,333 | 10,000 | 6,667 | 3,333 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 33,849 | $6.55M | $10.46M | - | $3.91M | 59.68% | -7.354% |
ABBV AbbVie Inc. | 6,406 | $1.03M | $1.61M | - | $581,327.34 | 56.65% | -2.513% |
ABT Abbott Laboratories | 8,032 | $888,879.88 | $848,982.4 | - | -$39,897.48 | -4.49% | +0.085% |
ACN Accenture plc Class A | 2,151 | $754,807.45 | $356,893.92 | - | -$397,913.53 | -52.72% | +1.611% |
ADI Analog Devices, Inc. | 6,871 | $1.36M | $2.52M | - | $1.16M | 85.04% | +0.202% |
AFL Aflac Inc. | 9,690 | $800,647.08 | $1.24M | - | $434,634.12 | 54.29% | +0.094% |
AMP Ameriprise Financial, Inc. | 2,269 | $903,300.71 | $1.24M | - | $335,210.32 | 37.11% | +0.253% |
AMZN Amazon.com Inc | 12,955 | $2.09M | $3.52M | - | $1.43M | 68.33% | +15.321% |
ANET Arista Networks, Inc. | 12,742 | $1.45M | $2.3M | - | $846,263.62 | 58.29% | +5.456% |
AXP American Express Company | 3,902 | $843,402.7 | $1.31M | - | $468,644.8 | 55.57% | -0.376% |
AZN AstraZeneca PLC American Depositary Shares | 2,807 | $553,071.77 | $476,179.48 | - | -$76,892.29 | -13.9% | -0.992% |
AZO AutoZone Inc. | 85 | $219,777.1 | $256,381.25 | - | $36,604.15 | 16.66% | +0.322% |
BAC Bank of America Corporation | 43,746 | $1.82M | $2.71M | - | $886,649.93 | 48.63% | +0.356% |
BKNG Booking Holdings Inc. | 1,131 | $160,476.46 | $218,169.89 | - | $57,693.43 | 35.95% | -0.176% |
BP BP p.l.c. Sponsored ADR | 5,949 | $205,032.36 | $269,013.78 | - | $63,981.42 | 31.21% | +2.261% |
BRK-A Berkshire Hathaway Inc. | 1 | $798,442 | $766,600 | - | -$31,842 | -3.99% | +0.21% |
BRK-B Berkshire Hathaway Inc. | 9,134 | $3.31M | $4.67M | - | $1.36M | 41.22% | +0.365% |
BUD Anheuser-Busch InBev S.A. ADR | 3,733 | $268,274.96 | $322,829.84 | - | $54,554.88 | 20.34% | +0.395% |
BX Blackstone Inc. | 10,228 | $1.33M | $1.31M | - | -$22,317.98 | -1.68% | -0.25% |
C Citigroup Inc. | 2,988 | $338,873.88 | $395,760.6 | - | $56,886.72 | 16.79% | +0.098% |